论文部分内容阅读
北京地区以活血化瘀冠心Ⅱ号方治疗冠心病心绞痛取得了较好疗效。临床观察到冠心Ⅱ号方能改善病人的甲皱微循环、抑制二磷酸腺苷(简称 ADP)诱导的血小板聚集。动物实验表明,冠心Ⅱ号方能抑制ADP和胶原诱导的家兔血小板聚集,并有扩张血管,增加冠脉流量等作用。为了进一步探讨活血化瘀
In Beijing, a good effect has been achieved with the treatment of coronary heart disease and angina pectoris with Huoxuehuayu Guanxin II. It is clinically observed that Guanxin II can improve the nailfold microcirculation and inhibit adenosine diphosphate (abbreviated ADP)-induced platelet aggregation. Animal experiments showed that Guanxin II can inhibit platelet aggregation induced by ADP and collagen in rabbits, and it also has the effect of dilating blood vessels and increasing coronary flow. In order to further explore blood circulation